Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma.

Teoh PJ, Chng WJ.

Biomed Res Int. 2014;2014:717919. Epub 2014 Jun 17. Review.

PMID:
25028664
[PubMed - as supplied by publisher]
Free PMC Article
2.

MicroRNA: Important Player in the Pathobiology of Multiple Myeloma.

Bi C, Chng WJ.

Biomed Res Int. 2014;2014:521586. Epub 2014 Jun 3. Review.

PMID:
24991558
[PubMed - as supplied by publisher]
Free PMC Article
3.

Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group.

Tse E, Chan TS, Koh LP, Chng WJ, Kim WS, Tang T, Lim ST, Lie AK, Kwong YL.

Bone Marrow Transplant. 2014 Jul;49(7):902-6. doi: 10.1038/bmt.2014.65. Epub 2014 Apr 28.

PMID:
24777195
[PubMed - in process]
4.

Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study.

Kim K, Lee JH, Kim JS, Min CK, Yoon SS, Shimizu K, Chou T, Kosugi H, Suzuki K, Chen W, Hou J, Lu J, Huang XJ, Huang SY, Chng WJ, Tan D, Teoh G, Chim CS, Nawarawong W, Siritanaratkul N, Durie BG.

Am J Hematol. 2014 Jul;89(7):751-6. doi: 10.1002/ajh.23731. Epub 2014 Apr 26.

PMID:
24723430
[PubMed - in process]
5.

LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.

Chong PS, Zhou J, Cheong LL, Liu SC, Qian J, Guo T, Sze SK, Zeng Q, Chng WJ.

Cancer Res. 2014 Jun 1;74(11):3043-53. doi: 10.1158/0008-5472.CAN-13-2321. Epub 2014 Mar 31.

PMID:
24686170
[PubMed - in process]
6.

p53 haploinsufficiency and functional abnormalities in multiple myeloma.

Teoh PJ, Chung TH, Sebastian S, Choo SN, Yan J, Ng SB, Fonseca R, Chng WJ.

Leukemia. 2014 Mar 14. doi: 10.1038/leu.2014.102. [Epub ahead of print]

PMID:
24625551
[PubMed - as supplied by publisher]
7.

Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model.

Siveen KS, Mustafa N, Li F, Kannaiyan R, Ahn KS, Kumar AP, Chng WJ, Sethi G.

Oncotarget. 2014 Feb 15;5(3):634-48.

PMID:
24504138
[PubMed - in process]
Free PMC Article
8.

Modified cIg-FISH protocol for multiple myeloma in routine cytogenetic laboratory practice.

Gole L, Lin A, Chua C, Chng WJ.

Cancer Genet. 2014 Jan-Feb;207(1-2):31-4. doi: 10.1016/j.cancergen.2013.12.001. Epub 2013 Dec 27.

PMID:
24485403
[PubMed - indexed for MEDLINE]
9.

CD137 ligand signalling induces differentiation of primary acute myeloid leukaemia cells.

Cheng K, Wong SC, Linn YC, Ho LP, Chng WJ, Schwarz H.

Br J Haematol. 2014 Apr;165(1):134-44. doi: 10.1111/bjh.12732. Epub 2014 Jan 15.

PMID:
24428589
[PubMed - indexed for MEDLINE]
10.

Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia.

Tan KB, Ling LU, Bunte RM, Chng WJ, Chiu GN.

Nanomedicine (Lond). 2013 Dec 3. [Epub ahead of print]

PMID:
24294981
[PubMed - as supplied by publisher]
11.

Direct costs associated with febrile neutropenia in inpatients with hematological diseases in Singapore.

Zhou YP, Jin J, Ding Y, Chee YL, Koh LP, Chng WJ, Chan DS, Hsu LY.

Support Care Cancer. 2014 Jun;22(6):1447-51. doi: 10.1007/s00520-013-2055-5. Epub 2013 Nov 28.

PMID:
24287505
[PubMed - indexed for MEDLINE]
12.

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG).

Ocio EM, Richardson PG, Rajkumar SV, Palumbo A, Mateos MV, Orlowski R, Kumar S, Usmani S, Roodman D, Niesvizky R, Einsele H, Anderson KC, Dimopoulos MA, Avet-Loiseau H, Mellqvist UH, Turesson I, Merlini G, Schots R, McCarthy P, Bergsagel L, Chim CS, Lahuerta JJ, Shah J, Reiman A, Mikhael J, Zweegman S, Lonial S, Comenzo R, Chng WJ, Moreau P, Sonneveld P, Ludwig H, Durie BG, Miguel JF.

Leukemia. 2014 Mar;28(3):525-42. doi: 10.1038/leu.2013.350. Epub 2013 Nov 20. Review.

PMID:
24253022
[PubMed - indexed for MEDLINE]
13.

Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group.

Kim SJ, Jung HA, Chuang SS, Hong H, Guo CC, Cao J, Hong XN, Suzuki R, Kang HJ, Won JH, Chng WJ, Kwong YL, Suh C, Song YQ, Zhu J, Tay K, Lim ST, Suzumiya J, Lin TY, Kim WS; Asia Lymphoma Study Group.

J Hematol Oncol. 2013 Nov 16;6:86. doi: 10.1186/1756-8722-6-86.

PMID:
24238138
[PubMed - in process]
Free Article
14.

T lymphocytes expressing a CD16 signaling receptor exert antibody-dependent cancer cell killing.

Kudo K, Imai C, Lorenzini P, Kamiya T, Kono K, Davidoff AM, Chng WJ, Campana D.

Cancer Res. 2014 Jan 1;74(1):93-103. doi: 10.1158/0008-5472.CAN-13-1365. Epub 2013 Nov 6.

PMID:
24197131
[PubMed - indexed for MEDLINE]
15.

Management of multiple myeloma in Asia: resource-stratified guidelines.

Tan D, Chng WJ, Chou T, Nawarawong W, Hwang SY, Chim CS, Chen W, Durie BG, Lee JH.

Lancet Oncol. 2013 Nov;14(12):e571-81. doi: 10.1016/S1470-2045(13)70404-2. Review.

PMID:
24176575
[PubMed - indexed for MEDLINE]
16.

Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival.

Reghunathan R, Bi C, Liu SC, Loong KT, Chung TH, Huang G, Chng WJ.

Oncotarget. 2013 Aug;4(8):1230-40.

PMID:
23985559
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

IMWG consensus on risk stratification in multiple myeloma.

Chng WJ, Dispenzieri A, Chim CS, Fonseca R, Goldschmidt H, Lentzsch S, Munshi N, Palumbo A, Miguel JS, Sonneveld P, Cavo M, Usmani S, Durie BG, Avet-Loiseau H; International Myeloma Working Group.

Leukemia. 2014 Feb;28(2):269-77. doi: 10.1038/leu.2013.247. Epub 2013 Aug 26. Review.

PMID:
23974982
[PubMed - indexed for MEDLINE]
18.

Unusual case of metachronous EBV-associated B-cell and NK/T-cell lymphoma mimicking polymyositis-diagnostic challenges and pitfalls.

Chan EH, Lu SJ, Petersson F, Tan KB, Chng WJ, Ng SB.

Am J Hematol. 2014 Jan;89(1):110-3. doi: 10.1002/ajh.23572. Epub 2013 Oct 15. Review. No abstract available.

PMID:
23963857
[PubMed - indexed for MEDLINE]
19.

Akt-induced phosphorylation of N-CoR at serine 1450 contributes to its misfolded conformational dependent loss (MCDL) in acute myeloid leukemia of the M5 subtype.

Nin DS, Ali AB, Okumura K, Asou N, Chen CS, Chng WJ, Khan M.

PLoS One. 2013 Aug 5;8(8):e70891. doi: 10.1371/journal.pone.0070891. Print 2013.

PMID:
23940660
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia.

Park JE, Yuen HF, Zhou JB, Al-Aidaroos AQ, Guo K, Valk PJ, Zhang SD, Chng WJ, Hong CW, Mills K, Zeng Q.

EMBO Mol Med. 2013 Sep;5(9):1351-66. doi: 10.1002/emmm.201202183. Epub 2013 Aug 8.

PMID:
23929599
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk